Education
About Us
Working with TipRanks
Follow Us
Northwest Biotherapeutics (NWBO)
:NWBO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.38M | $ 1.93M | $ 1.68M | $ 1.00M | $ 1.29M |
| Gross Profit | $ 1.38M | $ -25.80M | $ 135.00K | $ -19.30M | $ -32.35M |
| Operating Income | $ -66.51M | $ -55.51M | $ -67.18M | $ -52.70M | $ -86.61M |
| EBITDA | $ -73.64M | $ -55.34M | $ -97.42M | $ 184.72M | $ -520.85M |
| Net Income | $ -83.78M | $ -62.60M | $ -105.03M | $ 179.13M | $ -529.82M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.17M | $ 2.13M | $ 6.96M | $ 15.17M | $ 9.98M |
| Total Assets | $ 26.73M | $ 27.86M | $ 31.32M | $ 40.16M | $ 32.90M |
| Total Debt | $ 67.44M | $ 45.56M | $ 26.25M | $ 37.94M | $ 19.86M |
| Net Debt | $ 65.27M | $ 43.43M | $ 19.29M | $ 22.77M | $ 9.87M |
| Total Liabilities | $ 121.22M | $ 74.92M | $ 159.43M | $ 164.15M | $ 395.85M |
| Stockholders' Equity | $ -94.49M | $ -46.98M | $ -128.10M | $ -123.99M | $ -362.95M |
| Cash Flow | |||||
| Free Cash Flow | $ -58.03M | $ -57.07M | $ -55.68M | $ -44.31M | $ -38.70M |
| Operating Cash Flow | $ -57.02M | $ -53.64M | $ -52.77M | $ -38.30M | $ -32.09M |
| Investing Cash Flow | $ -1.01M | $ -3.44M | $ -2.90M | $ -6.01M | $ -8.14M |
| Financing Cash Flow | $ 56.78M | $ 52.76M | $ 41.97M | $ 48.13M | $ 52.70M |
Northwest Biotherapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.